The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-α converting enzyme (TACE)
The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-α converting enzyme (TACE)
复制标题
DOI:
10.1359/jbmr.2004.19.1.147
复制
发表时间:
2004-01-01
影响因子:
6.2
通讯作者:
Zannettino, ACW
中科院分区:
文献类型:
--
作者:
Pan, BQ;Farrugia, AN;Zannettino, ACW
Bisphosphonates are used to prevent osteoclast-mediated bone loss. Zoledronic acid inhibits osteoclast maturation indirectly by increasing OPG protein secretion and decreasing transmembrane RANKL expression in human osteoblasts. The decreased transmembrane RANKL expression seems to be related to the upregulation of the RANKL sheddase, TACE.